Daymark Wealth Partners, LLC Aquestive Therapeutics, Inc. Transaction History
Daymark Wealth Partners, LLC
- $2.79 Billion
- Q3 2025
A detailed history of Daymark Wealth Partners, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Daymark Wealth Partners, LLC holds 25,278 shares of AQST stock, worth $177,957. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,278
Previous 17,500
44.45%
Holding current value
$177,957
Previous $57,000
147.37%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
127Shares Held
47.4MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$69.1 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$38.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$30.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.98MShares$21 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$15.4 Million0.32% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $376M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...